Preventing Pluripotent Cell Teratoma in Regenerative Medicine Applied to Hematology Disorders. [electronic resource]
Producer: 20190708Description: 382-393 p. digitalISSN:- 2157-6564
- Animals
- Caspase 9 -- genetics
- Cell Line
- Cell Proliferation
- Cell Transformation, Neoplastic -- drug effects
- Dose-Response Relationship, Drug
- Gene Expression Regulation, Neoplastic
- Genes, Transgenic, Suicide
- Hematologic Diseases -- surgery
- Hematopoietic Stem Cell Transplantation -- adverse effects
- Hematopoietic Stem Cells -- drug effects
- Humans
- Imidazoles -- pharmacology
- Induced Pluripotent Stem Cells -- drug effects
- Mice, Inbred NOD
- Mice, SCID
- Naphthoquinones -- pharmacology
- Phenotype
- Regenerative Medicine -- methods
- Risk Assessment
- Survivin -- antagonists & inhibitors
- Tacrolimus -- analogs & derivatives
- Teratoma -- genetics
- Time Factors
- Tumor Burden
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.